Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My PPS is $6.20. Have built approximately 50% of my full desired position. GLTA
12:45 today at PODD
Lexaria Bioscience Corp. (Nasdaq:LEXX) Proprietary Drug Delivery Technology DehydraTECH™
Lexaria Bioscience Corp.’s proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company’s technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules...
Viewed the price in the teens today as a great time to build a re-entry. My buy orders are many at that price and below.
I have researching the warrants. Can someone share with me what a warrant consists of, please. Thank you in advance.
A general question for the board at large here. I discovered LEXX earlier this year. It has been the most profitable stock I have ever traded. Are most members here from pre-split days? The lack of posts puzzles me. Facts, not Bunka, have been my only guide in decision making. Still long and strong with great optimism for LEXX and shareholders.
$51,990 on the bid @$5.36.
Bunko quote: " We’re filling up our binders and creating lots of data and information… so when we knock on the doors of Pfizer and Johnson and Johnson, we can show them what we can do with their drugs,”
My first purchase of LEXX occurred on March 24 of this year. I now own over a thousand shares from profits alone. The rest on my dime. I believe still, a dime well spent, invested, with further rewards anticipated. "Bunko" has never entered in to my thinking. Facts are better than Bunko's prose.
One account sold 64k shares of LEXX. I'm buying all day long now.
Have been purchasing my favorite shares today. LEXX is present my "All In" company. My past all in choices have always been fruitful. GLTAL
Sold thousands of shares today. Will reload on the slope downward from here. Will wait for the next tent pole and repeat. Holding a long term core for the future as an investment. GLTA
Unicorn? Try 4X unicorn:
Reduces time of onset
Many prescription drugs and active ingredients require 60-120 minutes to transit the stomach, intestine and liver on their journey to the bloodstream. DehydraTECH reduces this time of onset to just minutes; tested and validated at between 10 – 30 minutes typically, and in some cases with onset possible in as little as 1.5-4.0 minutes.
Increases bio-absorption
Increases bio-absorption to the bloodstream by 100 – 500%, typically, and across the blood brain barrier in repeated animal tests of up to 1,900%. These dramatic efficiency improvements open new possibilities for classes of drugs such as antiviral, non-combusted nicotine and more.
Masks taste/odor
Eliminates the strong tastes/odors of lipophilic compounds, without the need for unwanted sugar or sweeteners. For consumer packaged goods, the avoidance of artificial or excessive sweeteners or flavoring agents can have a major impact to consumer acceptance.
Avoids first-pass liver metabolism
Testing has evidenced that DehydraTECH may deliver molecules through the lymphatic system instead of being subject to immediate “first pass” liver exposure, potentially mitigating unwanted side effects.In a human clinical study, Lexaria confirmed that liver metabolites of the active ingredient tested were lower than in the positive control, indirectly supporting this hypothesis.
Each point is a potential 10 bagger. Together, this investor is All-In on this Grand Slam opportunity. If you love someone, tell them of Lexaria.
Netcapital Inc. Reports Nine Month Revenue Growth of 137% to $3.8 Million
Earnings Review Conference Call to be Held on March 31, 2021 at 12:00 EST
Highlights:
Fiscal nine month revenues of $3,770,813, an increase of 137%
Net income of $103,535, with earnings per share of 11 cents
Book value per share of $6.03
Triple digit y/y growth across key user metrics
Perhaps the 100+ employees acquired with Netcapital?
MondayFunday
"Dear Investor,
It's an exciting month for KingsCrowd! Deal flow is high -- we're currently tracking more than 530 active deals -- and with the new raise limits set to kick in on Monday, we're expecting to see a major influx of startups looking to raise $5 million."
CNN Travel has picked up the Space Hotel story and is sharing it today. Whether it will ever exist or not is less important. We got paid. Money flow through Netcapital is increasing more than twice the industry average.
That was my $6.66 bid which filled. Have many more bids at lesser prices
FYI: $6.94 was the share price of two shares sold to me today, which fell into my standing bids of hundreds.
For general knowledge, 1 of my thousands of shares sold at $9.88 yesterday.
Yes, Femto! I have been studying, what is now Netcapital, NCPL, for some time now. It is a core holding of mine and am pleased with all that I learn and with all that they are doing. A pink with a P/E and such a low one, is a rare find.
$8.00 Bid!
I have yet to find any news for SpaceoutVR this decade. If you can assist, it would be welcomed.
Pleased to assist, fallin. Yes, there will be a reverse split 2000 for 1. VSTR website has details, check it out. Yes they will be seeking ticker change and striving for NASDQ listing. New company to be deemed Net Capital Inc.
Welcome to NetCapital!
"(1) change the Company’s corporate name from ValueSetters, Inc. to NetCapital Inc. (the “Name Change”); and
(2) amend the Company’s Articles of Incorporation to effect a stock combination, or reverse stock split, pursuant to which up to 2,000 shares of our common stock would be exchanged for one new share of common stock (the “Reverse Split”).
Based on the number of shares currently issued and outstanding, immediately following the Reverse Split, the Company will have approximately 415,000 shares of Common Stock issued and outstanding (without giving effect to rounding for fractional shares) based on the ratio for the Reverse Split of 1-for-2,000."
There is a wealth of information on Valuesetters and its Portfolio Company's on Twitter. Good DD includes Twitter. GLTA
Twitter #KnowYourValueSetters @ValueSettetsinc $VSTR
You will find great data. Spread the word.
A good way to start the day. Add Zelgor, Kingscrowd, Netcapital, Deucedrone, and Holler and as I shall, buy more VSTR:
"Our revenues for fiscal 2020 increased by $739,946, or 73%, to $1,753,558 as compared to $1,013,612 reported for fiscal 2019. The increase in revenues is attributable to our consulting services. We have expanded our consulting business, which concentrates on providing assistance with capital raising, strategy, technology consulting and marketing.
Our operating income increased by $522,789, or 84%, in fiscal 2020 to $1,147,222, as compared to $624,433 in fiscal 2019."
Not only do these women rock, they rock the numbers!
Our operating income increased by $522,789, or 84%, in fiscal 2020 to $1,147,222, as compared to $624,433 in fiscal 2019."
"Significant change!" All good.
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? x Yes ¨ No
From VSTR:
What do angel investors want to know before they invest? What makes a startup attractive to investors? On our new episode of "Ask the Angel Investor," $VSTR CEO and #AngelInvestor
@cecilialenk
gives us the inside scoop!
Watch it here! https://hubs.ly/H0t33dT0
August will august! Buy now under .005 while you can. I believe shares will soon be never this low again.
From Zelgor, on Twitter:
ICYMI: We released new builds of Noobs in Space and NoobTubes to testers last week.
Want to try them for yourself? Sign up to be a tester today: https://bit.ly/37zBttX
Explosive growth!
From Kingscrowd:
Equity crowdfunding turned four back in May. And much has happened in its four-year (and counting) run. Investors have given more than $350 million to more than 1500 startup companies since 2016.
The total number of investors using crowdfunding platforms has skyrocketed as well. In 2016, only 61,000 investors participated in crowdfunding raises. Last year that number jumped to 265,000! And 80% of those were non accredited investors. Regulation Crowdfunding deals have democratized startup investing by giving so many everyday investors an opportunity that didn’t exist just four years ago.
I enjoy all the banter and insight on this board. I am also enjoying all the data I find daily on for @ValueSettersinc, Netcapital, Zelgor, Kingscrowd, Deucedrone, Holler, $VSTR, #KnowYourValueSetters on Twitter. You'll wish to check it out if you like gleaning more of VSTR
Some great data points on Twitter:
@ValueSettersInc
#KnowYourValueSetters
$VSTR
@DeuceDrones
@KingsCrowdTech
@Netcapital
@ZelgorGames
From Valuesetters:
Congratulations to $VSTR client
@ZelgorGames
, winner of last night’s Founders Live Prime Time pitch competition! Great work! Party popper.
#VSTR #equitycrowdfunding #equities #cfa #finance #mba #investing
Quote Tweet
From Valuesetters:
$VSTR's new YouTube series "Ask the CEO" and "Ask the Angel Investor" is in the works! Let us know what questions YOU have over on our Instagram Story today, and be sure to follow us there for updates!
https://hubs.ly/H0sB89m0
#investing #VSTR #ceo #VSTR #equities #cfa #finance